Moneycontrol Bureau
Shares of Wockhardt rose 5 percent intraday on Monday after Citi upgraded the stock to buy from sell. The brokerage has also revised its target price to Rs 1880 per share following firm December quarter results.
Citi has even increased its FY16-17 core EPS by 2/10 percent based on progress on regulatory front and stated that resolution of 483s at Morton Grove is positive. It also adds that risk-reward looks reasonable for Wockhardt.
Meanwhile, last week Macquarie also had upgraded Wockhardt to outperform from neutral with a revised one-year target of Rs 1700 (from Rs 410) per share. The brokerage had a cautious view on the stock for past year, awaiting better visibility by regulatory issues and future approvals but Form 483 issued by the US FDA in early 2014 on the Morton Grove US facility has now been resolved, which provides significant comfort around the sustainability of the remaining US business.
Wockhardt’s consolidated total income rose 11.8 percent (up 34.3 percent Q-o-Q) to Rs 1,382 crore during October-December quarter from Rs 1,236.4 crore in the year-ago period.
At 13:14 hrs Wockhardt was quoting at Rs 1,289.95, up Rs 54.60, or 4.42 percent on the BSE.
(Posted by Nasrin Sultana)
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
